期刊文献+

sTRAIL蛋白原核表达载体的构建、表达及抗肿瘤活性研究

Construction and Expression of Prokaryotic Expression Vector of Soluble TNF- related Apoptosis Inducing Ligand and Its Anti-tumor Activity
原文传递
导出
摘要 目的:从HL-60细胞中获得了sTrail基因片段,优化蛋白表达条件,并研究其抗肿瘤活性。方法:培养HL-60细胞,提取总RNA,通过RT-PCR扩增sTRAIL蛋白基因片段,并将目的基因克隆至原核表达载体p ET28a上,并电击转化E.coli BL21(DE3),IPTG诱导表达,优化蛋白表达条件,Ni-IDA柱纯化重组蛋白,SDS-PAGE蛋白电泳,胶内酶解质谱鉴定。纯化后的重组蛋白作用HUVEC,He La,Hep-3B,HCT-116,MDA-MB-231,H460细胞检测蛋白生物学作用。结果:DNA测序结果证实成功构建了重组质粒p ET28a-sTrail,SDS-PAGE蛋白电泳,胶内酶解质谱检测显示成功表达sTRAIL蛋白,MTT法和流式细胞术结果显示,sTRAIL蛋白对肿瘤细胞包括He La,HCT-116,MDA-MB-231,H460,Hep-3B细胞有良好的生物活性,对正常的HUVEC细胞无毒性。结论:成功构建可以高效表达sTRAIL蛋白的原核表达载体,优化蛋白的表达和纯化后所得sTRAIL蛋白具有良好的抗肿瘤生物活性,为研究和发展利用sTRAIL蛋白作为临床治疗抗肿瘤药物提供了重要基础。 Purpose: To study the induced expression condition and anti-tumor activity of protein sTRAIL from human HL-60 cell. Methods: Genomic RNA was extract from the human HL-60 cell. The sTrail gene segment was amplified with RT-PCR and cloned into the prokaryotic expression vector pET28a. The final expression vector pET28a-sTrail was transformed into E. coli BI21 (DE3) for sTRAIL expression. Through IPTG induced, SDS-PAGE and LC-MS were used to determine the correct expression of sTRAIL. After purification by nickel-affinity chromatography, the recombinant sTRAIL was used to HUVEC, HeLa, Hep-3B, HCT-116, MDA- MB-231 and H460 cells. Result: The recombinant plasmid pET28a-sTrail was successfully built by the analysis of DNA sequencing. The result of SDS-PAGE show that sTRAIL gene was successfully expressed in E. coli BL21 (DE3) and identified by LC-MS. The purified sTRAIL inhibited the growth of HeLa, HCT-116, MDA-MB-231, H460 and Hep-3B cell while not HUVEC. Flow cytometry showed the inducing apoptosis of Hep-3B cells by sTRAIL. Conclution: The prokaryotic expression vector of sTRAIL was successfully built, and the purified protein sTRAIL exhibited anti-tumor activity. This provided an important foundation for using sTRAIL protein as a antitumor drugs of clinical treatment.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2015年第12期1-7,共7页 China Biotechnology
基金 国家国际合作项目(2011DFA32610) 国家"973"计划专项(2012CB722301) 国家"863"计划(2011AA10A203) 湖南省协同创新中心项目(20134486)资助项目
关键词 肿瘤坏死因子相关凋亡配体 基因克隆 原核表达 蛋白纯化 抗肿瘤活性 TNF-related apoptosis inducing ligand purification Antineoplastic activity Gene cloning Prokaryotic expression Protein
  • 相关文献

参考文献12

  • 1Wiley S R,Schooley K,Cmolak P J,et al.Identification and characterization of a new member of the TNF family that induce apoptosis.Immunity,1995,3(6):673-682. 被引量:1
  • 2Pitti R M,Marsters S A,Ruppert S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family.J Biol Chem,1996,271(22):12687-12690. 被引量:1
  • 3Ashkenazi A,Dixit V M.Death receptor:signaling and modulation.Science,1998;281(5381):1305-1308. 被引量:1
  • 4Bouralexis S,Findlay D M,Evdokiou A.A death to the bad guys:targeting cancer via Apo2L/TRAIL.Apoptosis,2005,10(1):35-51. 被引量:1
  • 5Ashkenazi A,Pai R C,Fong S,et al.Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clinic Invest,1999,104(2):155-162. 被引量:1
  • 6Simons M P,Nauseef W M,Griffith T S,et al.Neutrophils and TRAIL:insights into BCG immunotherapy for bladder cancer.Immunol Res,2007,39(1/2/3):79-93. 被引量:1
  • 7Dorsey J F,Mintz A,Tian X,et al.Tumor necrosis factorrelated apoptosis-inducing ligand(TRAIL)and paclitaxelhave cooperative in vivo effects against glioblastoma multiforme cells.Mol Cancer Ther,2009,8(12):3285-3295. 被引量:1
  • 8Ricci M S,Kim S H,Ogi K,et al.Reduction of TRAIL-induce Mcl-1 and c IAP2 by c-Myc or sorafenib sensitizes resistant human cancer sells to TRAIL-induced death.Cancer Cell,2007,12:66-80. 被引量:1
  • 9Long Xiaobin,Gou Y R,Luo M,et al.Soluble expression,purification,and characterization of active recombinant human tissue plasminogen activator by auto-induction in E.coli.BMC Biotechnology,2015,15(13):1-9. 被引量:1
  • 10李淑娟,孙永亮,胡道道,陈超,崔亚丽.金属螯合亲和层析介质用于六聚组氨酸融合蛋白的纯化研究[J].生物工程学报,2007,23(5):941-946. 被引量:13

二级参考文献32

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部